Nuclear Factor Kappa B is a Promising Therapeutic Target in Inflammatory Lung Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|6|661-668

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.6, 2006-06, pp. : 661-668

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Nuclear Factor-&kgr;B in Inflammatory Lung Disease

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 3, 2010-07 ,pp. : 197-205

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer

By  

Current Drug Targets, Vol. 18, Iss. 2, 2016-12 ,pp. : 232-253

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Factor Kappa B: A Potential Target for Anti-HIV Chemotherapy

By  

Current Medicinal Chemistry, Vol. 10, Iss. 16, 2003-08 ,pp. : 1603-1615

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Factor Erythroid 2 - Related Factor 2 Signaling in Parkinson Disease: A Promising Multi Therapeutic Target Against Oxidative Stress, Neuroinflammation and Cell Death

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 8, 2012-12 ,pp. : 1015-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Effect of Ribbon-Type Nuclear Factor-&kgr;B Decoy Oligonucleotides in a Rat Model of Inflammatory Bowel Disease

By  

Current Gene Therapy, Vol. 12, Iss. 6, 2012-12 ,pp. : 484-492

Bentham Science Publishers

Access to resources Recommend Favorite